about vcu massey cancer center · 9:00 - 9:30 am dr. drew moghanaki, non-surgical management of...

2
5 th annual VCU Massey - CMH Cancer Symposium All speakers are affiliated with VCU Health. VCU Health Community Memorial Hospital Education Center Auditorium 125 Buena Vista Circle • South Hill, VA (434) 447-3151 Saturday, September 9 7:30 am to 1:15 pm Register for the 2017 Cancer Symposium today! This is a FREE educational conference. Online registration is required and space is limited, so please register early. Please register online at cme.vcuhealth.org. Registration deadline: September 7, 2017 For more information, call CJ James, Event Coordinator at VCU Massey Cancer Center, at (804) 828-3998. VCU Massey Cancer Center is among the top 4 percent of cancer centers in the country and is one of two in the state designated by the National Cancer Institute to lead and shape America’s cancer research efforts. Founded in 1974, Massey is dedicated to discovering, developing, delivering and teaching effective means to prevent, detect, treat and cure cancer through innovative research, patient care and education. Massey conducts cancer research at every level, including basic science, translational, clinical and population sciences research. A major strength for Massey is in facilitating the translation and real-world application of research discoveries into improved treatments and patient care as well as advances in cancer prevention and control. About VCU Massey Cancer Center Massey is nationally recognized for its work in cancer disparities, studying the socioeconomic and cultural forces causing or contributing to disparities in cancer outcomes. Massey also serves as a vital resource for education. Additionally, Massey provides comprehensive, award-winning cancer care with a full range of medical and support services, the highest- quality treatments, advanced technologies and a compassionate approach. Massey treats patients with all kinds of cancer, including rare and complex cancers. World-class outpatient and inpatient care are delivered at Massey at various sites across the state by multidisciplinary teams of leading specialists who collaborate to fully coordinate and customize each patient’s course of treatment. Massey boasts the state’s largest, most comprehensive bone marrow transplant program and is an internationally recognized pioneer in palliative care.

Upload: others

Post on 30-Jul-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: About VCU Massey Cancer Center · 9:00 - 9:30 am Dr. Drew Moghanaki, Non-surgical Management of Pancreas and Liver Cancers: The Role of Sterotactic Radiotherapy Learning objectives:

5th annual VCU Massey - CMH Cancer Symposium

All speakers are affiliated with VCU Health.

VCU Health Community Memorial HospitalEducation Center Auditorium

125 Buena Vista Circle • South Hill, VA(434) 447-3151

Saturday, September 97:30 am to 1:15 pm

Register for the 2017 Cancer Symposium today! This is a FREE educational conference. Online registration is required and space is limited, so please register early. Please register online at cme.vcuhealth.org.

Registration deadline: September 7, 2017

For more information, call CJ James, Event Coordinator at VCU Massey Cancer Center, at (804) 828-3998.

VCU Massey Cancer Center is among the top 4 percent of cancer centers in the country and is one of two in the state designated by the National Cancer Institute to lead and shape America’s cancer research efforts. Founded in 1974, Massey is dedicated to discovering, developing, delivering and teaching effective means to prevent, detect, treat and cure cancer through innovative research, patient care and education.

Massey conducts cancer research at every level, including basic science, translational, clinical and population sciences research. A major strength for Massey is in facilitating the translation and real-world application of research discoveries into improved treatments and patient care as well as advances in cancer prevention and control.

About VCU Massey Cancer CenterMassey is nationally recognized for its work in cancer disparities, studying the socioeconomic and cultural forces causing or contributing to disparities in cancer outcomes. Massey also serves as a vital resource for education.

Additionally, Massey provides comprehensive, award-winning cancer care with a full range of medical and support services, the highest-quality treatments, advanced technologies and a compassionate approach. Massey treats patients with all kinds of cancer, including rare and complex cancers. World-class outpatient and inpatient care are delivered at Massey at various sites across the state by multidisciplinary teams of leading specialists who collaborate to fully coordinate and customize each patient’s course of treatment. Massey boasts the state’s largest, most comprehensive bone marrow transplant program and is an internationally recognized pioneer in palliative care.

Page 2: About VCU Massey Cancer Center · 9:00 - 9:30 am Dr. Drew Moghanaki, Non-surgical Management of Pancreas and Liver Cancers: The Role of Sterotactic Radiotherapy Learning objectives:

7:30 am Breakfast and Pharmaceutical Exhibit

7:50 am Welcome Remarks and Introduction Dr. Steve Grossman

8:00 am Gastrointestinal Cancers 8:00 - 8:30 am Dr. Brian Kaplan, Management of Pancreatic Cancer Learning objectives: Describe the current multidisciplinary treatment of pancreatic cancer to include the use of

American Joint Committee on Cancer (AJCC) or other appropriate staging in clinical practice, which includes the use of appropriate prognostic indicators and evidence-based national guidelines used in treatment planning.

8:30 - 9:00 am Dr. Scott Matherly, Hepatocellular Cancer: Screening and Treatment Learning objectives: List three groups at risk for hepatocellular cancer, explain who should be screened for

hepatocellular cancer, and recognize the most common treatments for liver cancer 9:00 - 9:30 am Dr. Drew Moghanaki, Non-surgical Management of Pancreas and Liver Cancers: The Role of Sterotactic Radiotherapy Learning objectives: Discuss the poor outcomes with conventional radiation, discuss the benefits of stereotactic

radiotherapy, and review the lessons learned from an active stereotactic radiotherapy program 9:30 - 10:00 am Dr. Andrew Poklepovic, Paradigm Shift of Immuno-Oncology in theTreatment of Cancer Learning objectives: Recognize the agents and common terms used in immuno-oncology (I/O), identify the

differences between standard chemotherapy and I/O therapy in terms of response, survival and toxicity, and recognize the unique side effect profile of I/O therapy and the role that healthcare providers of all disciplines play in the evaluation and management

10:00 - 10:30 am Dr. Ammer Shah, Thyroid Cancer Learning objectives: Describe evaluation of thyroid nodules; Define diagnosis of thyroid cancer to include the

use of American Joint Committee on Cancer (AJCC) or other appropriate staging in clinical practice, which includes the use of appropriate prognostic indicators and evidence-based national guidelines used in treatment planning; Describe management of thyroid cancer

10:30 am Coffee Break and Pharmaceutical Exhibit

10:45 am Genitourinary Cancers10:45 - 11:15 am Dr. Jinxing Yu, Update on Prostate Multiparametric MRI and Ultrasound/MRI Guided Fusion Biopsy Learning objectives: Discuss updated information on multiparametric MRI (mp-MRI) of prostate cancer and

Ultrasound/MRI guided fusion biopsy of prostate, demonstrate clinical indications of prostate mp-MRI, and discuss advantages of US/MRI guided fusion biopsy of prostate

11:15 - 11:45 am Dr. Riccardo Autorino, Current Role of Robotic Surgery in Urology Learning objectives: Describe the current status of robotic surgery in urology, identify patients who are

appropriate candidates for robotic urologic surgery, and describe perioperative management and follow-up of patient undergoing robotic urologic surgery

11:45 am - 12:15 am Dr. Drew Moghanaki, Update on Local Treatment Options for High-risk Prostate Cancer Learning objectives: Discuss the benefit of early detection for aggressive prostate cancer, compare the

outcomes with surgery, conventional radiotherapy, and brachytherapy, and assure the audience that there is no proven survival benefit of any one treatment over the other

12:15 pm Lunch

AGENDA Saturday, September 9th

The deadline to register is September 7, 2017.

Accreditation and Educational Credit

PhysiciansVCU Health Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

VCU Health Continuing Medical Education designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing ANCC and the Virginia Board of Nursing accept AMA PRA Category 1 Credits™ from organizations accredited by the ACCME for CNE contact hour requirements.

Physician AssistantsAAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Our target audience for this medical symposium is primary care health providers, specialists, hospital medical and nursing staff, pharmacists and other medical professionals.